Can the Time Window for Administration of Thrombolytics in Stroke be Increased?

ISSN： 1172-7047

Source： CNS Drugs, Vol.17, Iss.14, 2003-01, pp. : 995-1011

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thrombolytics: no survival benefit in patients aged > 75 years?

Inpharma, Vol. 1, Iss. 1241, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Is There an Increased Risk of Stroke Associated with Oral Contraceptives?

By Zeitoun K. Carr B.R.

Drug Safety, Vol. 20, Iss. 6, 1999-06 ,pp. : 467-473

Adis International

Access to resources Recommend Favorite

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?

By Demchuk Andrew M.

Drugs, Vol. 72, Iss. 14, 2012-10 ,pp. : 1833-1845

Adis International

Access to resources Recommend Favorite

Methylprednisolone for Acute Relapses of Multiple Sclerosis: Can Oral Replace Intravenous Administration?

By Uitdehaag B.M.J.

CNS Drugs, Vol. 10, Iss. 4, 1998-10 ,pp. : 233-238

Adis International

Access to resources Recommend Favorite

Can Sequential Administration Minimise the Cost of High Dose Chemotherapy?: An Economic Assessment in Inflammatory Breast Cancer

By Marino P.

PharmacoEconomics, Vol. 21, Iss. 11, 2003-01 ,pp. : 807-818

Adis International

Access to resources Recommend Favorite